Stephen Redenti and Kunwui Huang
Machine learning technology, to identify extracellular vesicle release and uptake targets, and corresponding novel drug database to inhibit retinoblastoma oncogenic signaling and metastasis.
For more information or to license this innovation:
- Log In
to view the innovation's details
- Sign Up
with discount code "ECOS"